# Starling Oncology, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 16:30 ET
- Period: 2025-11-03
- Accession: 0001079973-25-001666
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001666/toi_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000107997325001666/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000107997325001666/toi_8k.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001079973-25-001666. Last ingested by Listed: Nov 11, 2026, 04:14 ET. No prices; not investment advice.